⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
GRCE News
Grace Therapeutics, Inc. Common Stock
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Grace Therapeutics, Inc. - GRCE
accessnewswire.com
GRCE
Form 8-K
sec.gov
GRCE
Grace Therapeutics Provides Regulatory Update on New Drug Application for GTx-104
globenewswire.com
GRCE
Grace Therapeutics Announces Abstract Highlighting STRIVE-ON Phase 3 Trial Results Accepted for Presentation at AAN 2026
globenewswire.com
GRCE
Grace Therapeutics to Present Data on the Unmet Medical Needs and Potential Benefits of GTx-104 in the Treatment of aSAH at Upcoming Medical Conferences
globenewswire.com
GRCE
Grace Therapeutics to Participate in the TD Cowen 46th Annual Health Care Conference
globenewswire.com
GRCE
Business-to-Business (B2B) Continuing Education Report 2026: A $10+ Billion Market by 2030, Driven by Rising Demand for Online Learning, AI Personalization, and Reskilling Programs - Forecast to 2035
globenewswire.com
ACN
NU
MSFT
ORCL
ADBE
WLY
COUR
SKIL
HSTM
GDEN
DLB
LTRX
SONO
GRCE
Grace Therapeutics Announces Third Quarter 2026 Financial Results, Provides Business Update
globenewswire.com
GRCE
Grace Therapeutics to Participate in 16th Annual Craig-Hallum Alpha Select Conference
globenewswire.com
GRCE
Grace Therapeutics Announces Second Quarter 2026 Financial Results, Provides Business Update
globenewswire.com
GRCE